Connect Biopharma Holdings Ltd
CNTB2.019USD
+0.019+0.97%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
111.78MMarket Cap
LossP/E TTM
Connect Biopharma Holdings Ltd
2.019
+0.019+0.97%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q1
FY2024H1
FY2023H1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-1585.11%-9.96M
---591.00K
74.41%-7.97M
---31.16M
Net income from continuing operations
-18.16%-10.27M
---8.69M
125.35%7.71M
---30.41M
Operating gains losses
5.49%173.00K
--164.00K
-6.11%476.00K
--507.00K
Other non-cash items
-179.78%-249.00K
---89.00K
96.19%-17.00K
---446.00K
Change in working capital
-108.75%-587.00K
--6.71M
-833.77%-17.89M
---1.92M
-Change in receivables
--781.00K
--0.00
-900.93%-3.21M
---321.00K
-Change in prepaid expenses
-206.53%-1.29M
--1.21M
----
----
-Change in payables and accrued expense
----
----
390.15%589.00K
---203.00K
-Change in other current assets
-800.00%-9.00K
---1.00K
104.74%23.00K
---485.00K
-Change in other current liabilities
-100.08%-5.00K
--6.62M
-2620.61%-13.33M
---490.00K
Cash from non-recurring investing activities
Cash from operating activities
-1585.11%-9.96M
---591.00K
74.41%-7.97M
---31.16M
Investing cash flow
Net cash from continuing investing activities
--79.00K
--0.00
50.87%436.00K
--289.00K
Capital expenditures
--81.00K
--0.00
50.87%436.00K
--289.00K
Net cash flow from disposal of fixed assets
--79.00K
--0.00
50.87%436.00K
--289.00K
Net cash flow from investment products
-322.29%-20.56M
--9.25M
-62.93%12.76M
--34.41M
Net cash flow from other investing activities
----
----
-25.71%-44.00K
---35.00K
Cash from non-current investing activities
Net cash flow from investing activities
-323.15%-20.64M
--9.25M
-63.98%12.28M
--34.09M
Financing cash flow
Cash flow from continuous financing activities
--2.00K
--0.00
62.30%-46.00K
---122.00K
Net cash flow from debt Issuance/repayment
----
----
-2.78%-148.00K
---144.00K
Net cash flow from common stock issuance/repurchase
----
----
-9.09%20.00K
--22.00K
Proceeds from stock option exercised by employees
--2.00K
--0.00
--82.00K
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
--2.00K
--0.00
62.30%-46.00K
---122.00K
Net cash flow
Beginning cash balance
-25.96%78.23M
--105.66M
34.17%106.01M
--79.01M
Current period cash flow changes
-461.73%-30.52M
--8.44M
60.33%4.17M
--2.60M
Effect of exchange rate changes
133.94%75.00K
---221.00K
57.55%-90.00K
---212.00K
Ending cash balance
-58.19%47.71M
--114.10M
35.00%110.17M
--81.61M
Free cash flow
-1598.82%-10.04M
---591.00K
73.25%-8.41M
---31.44M
Currency unit
USD
USD
USD
USD
Audit opinions
--
--
--
--
